Executive Director
Eli Lilly and Company
Indianapolis, Indiana
Dr. Sperry is an Executive Director in Synthetic Molecule Design & Development at Lilly Research Laboratories. With over 20 years of experience in the pharmaceutical industry, Dr. Sperry has established himself as a leading expert in dissolution, biopharmaceutics, and drug product design. He obtained a B.S. degree in chemistry from Indiana University, Bloomington, IN and a Ph.D. degree in physical chemistry from the University of Rochester, Rochester, NY. After receiving his degree, he took a postdoctoral research scientist position at Pharmacia & Upjohn and shortly thereafter accepted a research scientist position at Pharmacia (later Pfizer), working in the area of in vitro methods and biopharmaceutics. He then moved to Bausch and Lomb where he developed commercial ophthalmic formulations for late-stage molecules. In 2007, Dr. Sperry joined Lilly Research Laboratories, where he created a group focusing on in vitro drug product performance techniques and predictions of in vivo performance. Over the past 17 years at Lilly, Dr. Sperry has held a variety of research-focused leadership positions in SMDD. He currently leads the Biopharmaceutics Modeling Group, developing new strategies for in vitro and in silico approaches to predict and control the performance of orally administered drugs.
Disclosure information not submitted.
Wednesday, November 12, 2025
1:30 PM - 2:30 PM CT